Four steps to build trust in COVID-19 vaccines
By Daniel R. Lucey M.D., MPH, FIDSA COVID-19 vaccine availability will be accelerated by receiving U.S. Food and Drug Administration emergency use authorization as opposed to the longer approval an…
By Daniel R. Lucey M.D., MPH, FIDSA COVID-19 vaccine availability will be accelerated by receiving U.S. Food and Drug Administration emergency use authorization as opposed to the longer approval an…
Countries’ investments in digital health related to COVID-19 vaccine delivery offer insights into how such efforts can strengthen health systems for future health shocks.
Age-standardized and adjusted mortality rates among people with HIV have declined substantially over time from 1999 through 2020, with the majority of decl
Avian influenza A(H5N1), or bird flu, is a disease caused by infection with avian influenza type A viruses. Bird flu is widespread in wild birds…
Darcy Wooten, MD, FIDSA discusses her piece in CID’s Voice of ID series, “The Arrivals Gate at Heathrow Airport.”
In an analysis of the CAMERA2 trial using a desirability of outcome ranking approach, treatment of Staphylococcus aureus bloodstream infections with a comb
In pediatric myeloablative allogeneic hematopoietic cell transplantation recipients, pre-transplant symptomatic upper respiratory tract infections, includi
The call for officer and director applications for the IDSA Board of Directors is now open. We are seeking volunteers for the office of Vice…
Understanding the roles of the microbiome and migration in antimicrobial resistance is essential for developing effective strategies for addressing this growing crisis.
Urge your House rep to sign onto funding letters